NCT00785213 - Drug-Drug Interaction Study Between Quinine Sulfate and Rosiglitazone | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Healthy

Interventions

DRUG

Rosiglitazone 4 mg Tablets

Rosiglitazone 4 mg tablet administered as a single oral dose on the morning of Day 1.

DRUG

Rosiglitazone 4 mg Tablets

Co-administered single oral doses of rosiglitazone 4 mg (1 x 4 mg tablet) and quinine sulfate 648 mg (2 x 324 mg capsules) on the morning of Day 7.

DRUG

Quinine Sulfate 324 mg Capsules

Co-administered single oral doses of rosiglitazone 4 mg (1 x 4 mg tablet) and quinine sulfate 648 mg (2 x 324 mg capsules) on the morning of Day 7.

Trial Locations (1)

Cetero Research, East Grand Forks